John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
CALL
Apollo Global Management
APO
$78.6B
| $563K | ﹤0.01% |
11,500
+5,400
| +89% | +$241K |
|
2427
Funko
FNKO
$377M
| $563K | ﹤0.01% |
54,218
-185,263
| -77% | -$1.53M |
|
2428
PUT
Stride
LRN
$3.56B
| $563K | ﹤0.01% |
+26,500
| New | +$658K |
|
2429
NETGEAR
NTGR
$581M
| $563K | ﹤0.01% |
13,851
-19,659
| -59% | -$669K |
|
2430
Peapack-Gladstone Financial
PGC
$800M
| $563K | ﹤0.01% |
24,750
+1,286
| +5% | +$25.5K |
|
2431
Gaia
GAIA
$39.2M
| $562K | ﹤0.01% |
56,894
-54,310
| -49% | -$568K |
|
2432
CALL
Vanguard Real Estate ETF
VNQ
$39.4B
| $561K | ﹤0.01% |
+6,600
| New | +$547K |
|
2433
Concentrix
CNXC
$1.64B
| $559K | ﹤0.01% |
+5,664
| New | +$566K |
|
2434
Hingham Institution for Saving
HIFS
$662M
| $559K | ﹤0.01% |
+2,586
| New | +$551K |
|
2435
Aclaris Therapeutics
ACRS
$963M
| $557K | ﹤0.01% |
+86,092
| New | +$363K |
|
2436
PUT
The Mosaic Company
MOS
$7.72B
| $557K | ﹤0.01% |
+24,200
| New | +$487K |
|
2437
CALL
TransDigm Group
TDG
$65.9B
| $557K | ﹤0.01% |
+900
| New | +$495K |
|
2438
Zai Lab
ZLAB
$2.94B
| $557K | ﹤0.01% |
4,116
-6,900
| -63% | -$702K |
|
2439
SiNtx Technologies
SINT
$10.4M
| $552K | ﹤0.01% |
18
+16
| +800% | +$580K |
|
2440
PUT
Becton Dickinson
BDX
$51.7B
| $550K | ﹤0.01% |
2,255
+1,230
| +120% | +$287K |
|
|
HTBK
2441
DELISTED
Heritage Commerce
HTBK
| $548K | ﹤0.01% |
61,797
-106,543
| -63% | -$864K |
|
2442
Paysign
PAYS
$798M
| $548K | ﹤0.01% |
118,195
+80,442
| +213% | +$421K |
|
2443
FreightCar America
RAIL
$238M
| $548K | ﹤0.01% |
+227,179
| New | +$499K |
|
2444
CALL
LendingTree
TREE
$429M
| $548K | ﹤0.01% |
+2,000
| New | +$594K |
|
|
2445
PUT
LendingTree
TREE
$429M
| $548K | ﹤0.01% |
2,000
-2,200
| -52% | -$654K |
|
2446
CALL
Yeti Holdings
YETI
$3.11B
| $548K | ﹤0.01% |
8,000
-33,600
| -81% | -$1.99M |
|
|
KW
2447
DELISTED
Kennedy-Wilson Holdings
KW
| $547K | ﹤0.01% |
+30,558
| New | +$478K |
|
2448
CALL
Elevance Health
ELV
$86.5B
| $546K | ﹤0.01% |
1,700
-300
| -15% | -$92.1K |
|
2449
PUT
Principal Financial Group
PFG
$23.9B
| $546K | ﹤0.01% |
11,000
+4,300
| +64% | +$197K |
|
2450
Petrobras
PBR
$115B
| $545K | ﹤0.01% |
48,526
-67,370
| -58% | -$598K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.